erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
subscribe today to be the first to to know about breaking news and special reports.
.". plemmons added, "particularly in a time when mental health resources for children appear to be static, and woefully scarce across the u.s".
.